Table 4.
Inter-assay agreement (number of samples positive in all 3 hrHPV assays; total n = 623) for each age group and cytology classification
| Age group | Inter-assay agreement % (N) |
Pap class | Bethesda classification | Inter-assay agreement % (N) |
|---|---|---|---|---|
| 29–33 | 65.7% (180) | 0 | - | 26.3% (5) |
| 34–38 | 52.0% (105) | 1 | Normal | 36.2% (339) |
| 39–43 | 51.0% (103) | 2 | ASC-US | 73.4% (113) |
| 44–48 | 41.7% (86) | 3a1 | LSIL | 90.8% (59) |
| 49–53 | 47.7% (72) | 3a2 | HSIL (moderate) | 95.8% (46) |
| 54–58 | 29.5% (43) | 3b | HSIL (severe) | 91.8% (56) |
| 59–63 | 31.8% (34) | 4 | CIS/AIS | 100% (5) |
| Total (N) | 623 | 623 |
Pap 0 = sample inadequate for cytology
ASC-US Atypical Squamous Cells of Undetermined Significance, LSIL Low-grade Squamous Intraepithelial Lesion, HSIL High-grade Squamous Intraepithelial Lesion, CIS Carcinoma in situ, AIS Adenocarcinoma in situ